Related references
Note: Only part of the references are listed.Phenotypic, genomic, and clinical associations of Circulating Tumor Cells (CTCs) lacking epithelial biomarkers in metastatic Castration Resistant Prostate Cancer (mCRPC)
Ryon P. Graf et al.
CANCER RESEARCH (2017)
Programmed death-ligand 1 (PD-L1) characterization of circulating tumor cells (CTCs) in muscle invasive and metastatic bladder cancer patients
Archana Anantharaman et al.
BMC CANCER (2016)
Androgen receptor expression predicts beneficial tamoxifen response in oestrogen receptor-α-negative breast cancer
Erik Hilborn et al.
BRITISH JOURNAL OF CANCER (2016)
Chromosomal Instability Estimation Based on Next Generation Sequencing and Single Cell Genome Wide Copy Number Variation Analysis
Stephanie B. Greene et al.
PLOS ONE (2016)
Association of AR-V7 on Circulating Tumor Cells as a Treatment-Specific Biomarker With Outcomes and Survival in Castration-Resistant Prostate Cancer
Howard I. Scher et al.
JAMA ONCOLOGY (2016)
PTEN loss in circulating tumour cells correlates with PTEN loss in fresh tumour tissue from castration-resistant prostate cancer patients
Elizabeth A. Punnoose et al.
BRITISH JOURNAL OF CANCER (2015)
Combined Androgen and Estrogen Receptor Status in Breast Cancer: Treatment Prediction and Prognosis in a Population-Based Prospective Cohort
Karin Elebro et al.
CLINICAL CANCER RESEARCH (2015)
Coexpression of androgen receptor and FOXA1 in nonmetastatic triple-negative breast cancer: ancillary study from PACS08 trial
Severine Guiu et al.
FUTURE ONCOLOGY (2015)
Heterogeneity of PIK3CA mutational status at the single cell level in circulating tumor cells from metastatic breast cancer patients
Marta Pestrin et al.
MOLECULAR ONCOLOGY (2015)
Androgen Receptor Expression Shows Distinctive Significance in ER Positive and Negative Breast Cancers
Julia Y. S. Tsang et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
PIK3CA Mutational Status in Circulating Tumor Cells Can Change During Disease Recurrence or Progression in Patients with Breast Cancer
Athina Markou et al.
CLINICAL CANCER RESEARCH (2014)
Circulating Tumor Cells and Response to Chemotherapy in Metastatic Breast Cancer: SWOG S0500
Jeffrey B. Smerage et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Androgen Receptor Expression and Outcomes in Early Breast Cancer: A Systematic Review and Meta-Analysis
Francisco E. Vera-Badillo et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
Quantitative characterization of androgen receptor protein expression and cellular localization in circulating tumor cells from patients with metastatic castration-resistant prostate cancer
Edwin E. Reyes et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2014)
Androgen receptor (AR) differential roles in hormone-related tumors including prostate, bladder, kidney, lung, breast and liver
C. Chang et al.
ONCOGENE (2014)
KAT6A, a Chromatin Modifier from the 8p11-p12 Amplicon is a Candidate Oncogene in Luminal Breast Cancer
Brittany Turner-Ivey et al.
NEOPLASIA (2014)
Clinical challenges in the molecular characterization of circulating tumour cells in breast cancer
E. S. Lianidou et al.
BRITISH JOURNAL OF CANCER (2013)
Differential Response to Neoadjuvant Chemotherapy Among 7 Triple-Negative Breast Cancer Molecular Subtypes
Hiroko Masuda et al.
CLINICAL CANCER RESEARCH (2013)
Phase II Trial of Bicalutamide in Patients with Androgen Receptor-Positive, Estrogen Receptor-Negative Metastatic Breast Cancer
Ayca Gucalp et al.
CLINICAL CANCER RESEARCH (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
RSF1 and Not Cyclin D1 Gene Amplification May Predict Lack of Benefit from Adjuvant Tamoxifen in High-Risk Pre-Menopausal Women in the MA.12 Randomized Clinical Trial
Dana Keilty et al.
PLOS ONE (2013)
Circulating Tumor Cells
Vicki Plaks et al.
SCIENCE (2013)
Fluid biopsy in patients with metastatic prostate, pancreatic and breast cancers
Dena Marrinucci et al.
PHYSICAL BIOLOGY (2012)
Androgen Receptor Expression and Breast Cancer Survival in Postmenopausal Women
Rong Hu et al.
CLINICAL CANCER RESEARCH (2011)
Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies
Brian D. Lehmann et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Androgen receptor expression in breast cancer in relation to molecular phenotype: results from the Nurses' Health Study
Laura C. Collins et al.
MODERN PATHOLOGY (2011)
Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment
Mario Giuliano et al.
BREAST CANCER RESEARCH (2011)
Androgen receptor overexpression induces tamoxifen resistance in human breast cancer cells
Francesca De Amicis et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
HER2 status of circulating tumor cells in patients with metastatic breast cancer: a prospective, multicenter trial
Tanja Fehm et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
Increased intratumoral androgens in human breast carcinoma following aromatase inhibitor exemestane treatment
Kiyoshi Takagi et al.
ENDOCRINE-RELATED CANCER (2010)
Cytomorphology of Circulating Colorectal Tumor Cells: A Small Case Series
Dena Marrinucci et al.
JOURNAL OF ONCOLOGY (2010)
Epidermal growth factor receptor expression escapes androgen regulation in prostate cancer: a potential molecular switch for tumour growth
A. M. Traish et al.
BRITISH JOURNAL OF CANCER (2009)
Androgen Receptor Inhibits Estrogen Receptor-α Activity and Is Prognostic in Breast Cancer
Amelia A. Peters et al.
CANCER RESEARCH (2009)
Are circulating tumor cells predictive of overall survival?
Klaus Pantel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2008)
Relationship of circulating tumor cells to tumor response, progression-free survival, and overall survival in patients with metastatic colorectal cancer
Steven J. Cohen et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Detection of mutations in EGFR in circulating lung-cancer cells
Shyamala Maheswaran et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex
Hannelore V. Heemers et al.
ENDOCRINE REVIEWS (2007)
Case study of the morphologic variation of circulating tumor cells
Dena Marrinucci et al.
HUMAN PATHOLOGY (2007)
Circulating tumor cells, disease progression, and survival in metastatic breast cancer
M Cristofanilli et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The development of androgen-independent prostate cancer
BJ Feldman et al.
NATURE REVIEWS CANCER (2001)